SI20151A - Metode in farmacevtske zmesi za aplikacijo železa hemodializnim in peritonealno dializnim pacientom - Google Patents

Metode in farmacevtske zmesi za aplikacijo železa hemodializnim in peritonealno dializnim pacientom Download PDF

Info

Publication number
SI20151A
SI20151A SI9720087A SI9720087A SI20151A SI 20151 A SI20151 A SI 20151A SI 9720087 A SI9720087 A SI 9720087A SI 9720087 A SI9720087 A SI 9720087A SI 20151 A SI20151 A SI 20151A
Authority
SI
Slovenia
Prior art keywords
iron
dialysis
patients
dialysate
solution
Prior art date
Application number
SI9720087A
Other languages
English (en)
Slovenian (sl)
Inventor
Ajay Gupta
Original Assignee
Ajay Gupta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/775,595 external-priority patent/US6689275B1/en
Application filed by Ajay Gupta filed Critical Ajay Gupta
Publication of SI20151A publication Critical patent/SI20151A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI9720087A 1996-12-31 1997-12-30 Metode in farmacevtske zmesi za aplikacijo železa hemodializnim in peritonealno dializnim pacientom SI20151A (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/775,595 US6689275B1 (en) 1996-12-31 1996-12-31 Method and pharmaceutical composition for replacing iron losses in dialysis patients
US5531597P 1997-08-07 1997-08-07
PCT/US1997/023719 WO1998029434A1 (en) 1996-12-31 1997-12-30 Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients

Publications (1)

Publication Number Publication Date
SI20151A true SI20151A (sl) 2000-08-31

Family

ID=26734087

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9720087A SI20151A (sl) 1996-12-31 1997-12-30 Metode in farmacevtske zmesi za aplikacijo železa hemodializnim in peritonealno dializnim pacientom

Country Status (18)

Country Link
EP (1) EP0951470B1 (es)
JP (2) JP3955639B2 (es)
AT (1) ATE311180T1 (es)
AU (1) AU736053B2 (es)
BR (1) BR9713653B1 (es)
CA (1) CA2276442C (es)
DE (1) DE69734781T2 (es)
DK (1) DK0951470T3 (es)
EA (1) EA002479B1 (es)
ES (1) ES2255115T3 (es)
HK (1) HK1023350A1 (es)
NO (1) NO317873B1 (es)
NZ (1) NZ336319A (es)
PL (1) PL191377B1 (es)
SI (1) SI20151A (es)
TR (1) TR199901518T2 (es)
WO (1) WO1998029434A1 (es)
YU (1) YU31299A (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906978A (en) * 1996-08-14 1999-05-25 Hemocleanse, Inc. Method for iron delivery to a patient by transfer from dialysate
US7670491B2 (en) 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
CA2422850C (en) 1999-09-22 2009-03-03 Advanced Renal Technologies High citrate dialysate and uses thereof
DE19951471A1 (de) * 1999-10-26 2001-05-03 Forssmann Wolf Georg Verwendung von Urodilatin zur Behandlung chronischer Niereninsuffizienz mit Nierenrestfunktionen
JP4838139B2 (ja) * 2003-10-28 2011-12-14 エモリー ユニバーシティー 透析液並びに透析液に関連した方法及びシステム
US8187467B2 (en) * 2003-12-30 2012-05-29 Ajay Gupta Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion
SE0400523D0 (sv) 2004-03-01 2004-03-01 Gambro Lundia Ab A medical solution, a method for producing said medical solution and use thereof
SE0402507D0 (sv) 2004-10-14 2004-10-14 Gambro Lundia Ab Medicinsk lösning, förfarande för framställning och användning därav
US7586589B2 (en) * 2005-09-24 2009-09-08 Beckman Coulter, Inc. Methods of determination of responsiveness to erythropoietin treatment
US7816404B2 (en) * 2007-07-20 2010-10-19 Rockwell Medical Technologies, Inc. Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
US7658952B2 (en) * 2007-10-11 2010-02-09 Baxter International Inc. Dialysis solutions containing pyrophosphates
AU2011242542B2 (en) * 2010-04-23 2014-11-27 Baxter Healthcare S.A. Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
AU2015200995B2 (en) * 2010-04-23 2016-09-08 Baxter Healthcare S.A. Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
JP2016507527A (ja) * 2013-02-01 2016-03-10 チャラク エルエルシー 可溶性ピロリン酸第二鉄を用いて鉄欠乏症を治療する方法
CA2929536A1 (en) * 2013-11-05 2015-05-14 Rockwell Medical, Inc. Methods of reducing doses of erythropoietin stimulating agents in hyporesponsive patients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3530216A (en) * 1967-10-05 1970-09-22 Hoffmann La Roche Vitamin compositions comprising riboflavin-5-phosphate and ferric pyrophosphate soluble
US3911915A (en) * 1972-09-05 1975-10-14 Einstein Coll Med Dialytic introduction of maltose into bloodstream
JPS5125238B2 (es) * 1973-08-14 1976-07-29
US4756838A (en) * 1980-02-21 1988-07-12 Veltman Preston Leonard Preparation of dry dialysate products
JPH0696586B2 (ja) * 1987-03-17 1994-11-30 花王株式会社 ヘキソ−スリン酸第一鉄塩及びその製造法並びにこれを含有する鉄供給剤
JPH0525051A (ja) * 1991-07-19 1993-02-02 Meiji Seika Kaisha Ltd 貧血予防・治療剤
JP3167402B2 (ja) * 1992-02-25 2001-05-21 仙味エキス株式会社 鉄吸収促進組成物

Also Published As

Publication number Publication date
JP4753379B2 (ja) 2011-08-24
BR9713653A (pt) 2000-04-11
NO317873B1 (no) 2004-12-27
AU736053B2 (en) 2001-07-26
YU31299A (sh) 2002-08-12
NZ336319A (en) 2000-12-22
JP2002531051A (ja) 2002-09-17
EP0951470A4 (en) 2003-05-02
JP2007106775A (ja) 2007-04-26
DK0951470T3 (da) 2006-03-27
TR199901518T2 (xx) 1999-12-21
JP3955639B2 (ja) 2007-08-08
EA199900609A1 (ru) 1999-12-29
PL334437A1 (en) 2000-02-28
ES2255115T3 (es) 2006-06-16
BR9713653B1 (pt) 2013-05-21
DE69734781D1 (de) 2006-01-05
NO993235L (no) 1999-08-27
EA002479B1 (ru) 2002-06-27
CA2276442C (en) 2012-01-17
ATE311180T1 (de) 2005-12-15
NO993235D0 (no) 1999-06-29
EP0951470A1 (en) 1999-10-27
HK1023350A1 (en) 2000-09-08
DE69734781T2 (de) 2006-07-20
CA2276442A1 (en) 1998-07-09
AU5617298A (en) 1998-07-31
WO1998029434A1 (en) 1998-07-09
PL191377B1 (pl) 2006-05-31
EP0951470B1 (en) 2005-11-30

Similar Documents

Publication Publication Date Title
US6779468B1 (en) Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients
JP4753379B2 (ja) 血液透析及び腹膜透析患者における鉄デリバリーのための方法及び医薬組成物
US6689275B1 (en) Method and pharmaceutical composition for replacing iron losses in dialysis patients
US4889634A (en) Dialysate solution containing hydroxypropyl-beta-cyclodextrin and method of using same
Macdougall et al. A randomized controlled study of iron supplementation in patients treated with erythropoietin
Macdougall Evolution of iv iron compounds over the last century
Vychytil et al. Iron status and iron supplementation in peritoneal dialysis patients
MXPA06014254A (es) Soluciones para dialisis peritoneal a base de bicarbonato.
CA2510788A1 (en) Biocompatible dialysis fluids containing icodextrins
US6333306B1 (en) Pharmaceutical combination preparations containing erythropoietin and iron preparations
WO2001000204A1 (en) Method and pharmaceutical composition for parenteral administration of iron
Simon Detoxification in hemosiderosis
RU2188033C2 (ru) Комбинированные фармацевтические препараты, содержащие эритропоэтин и препараты железа
AU2014264537B2 (en) Dialysis formulation
MXPA99006187A (es) Metodo y composicion farmaceutica para el suministro de hierro en pacientes de hemodialisis y dialisis peritoneal
Steinhauer Effects of long-term treatment with human recombinant erythropoietin in patients on CAPD
Norris et al. Minimizing anemia in the chronic hemodialysis patient
JP6578293B2 (ja) 反応性が低下した患者のエリトロポエチン刺激剤の用量を減少させる方法
Vogel et al. Iron management: Innovative solutions to persistent challenges--focus on Ferrlecit
Capodicasa et al. CAPD+ Hemoperfusion once a week for end stage renal disease
Laušević et al. Experience with a High-Dose Oral Iron Sulfate and Gluconate in Peritoneal Di-alysis Patients
Szwed et al. The Effect of Hemodialysis on Oxygen Transport in Chronic Uremics
Winney et al. Anaemia in patients with chronic renal failure treated by intermittent haemodialysis-aetiology and treatment
Rutkowski et al. Subcutaneous r-Hu EPO therapy appeared an effective and convenient method of treatment ofanemia in predialysis patients, which is in agreement with other data (1-4). Using of hematological autoanalyser Technicon Hl allowed to determine the
Henrich New therapeutic strategies for acute renal failure in the intensive care unit